Cis-9, trans-11 and trans-10, cis-12 CLA Mixture does not Change Body Composition, Induces Insulin Resistance and Increases Serum HDL Cholesterol Level in Rats

被引:13
|
作者
de Almeida, Mariana Macedo [1 ]
de Souza, Yamara Oliveira [1 ]
Potente Dutra Luquetti, Sheila Cristina [2 ]
Sabarense, Cephora Maria [2 ]
do Amaral Correa, Jose Otavio [3 ]
Santos da Conceicao, Ellen Paula [4 ]
Lisboa, Patricia Cristina [4 ]
de Moura, Egberto Gaspar [4 ]
Andrade Soares, Sara Malaguti [5 ]
Moura Gualberto, Ana Cristina [5 ]
Gameiro, Jacy [5 ]
Sundfeld da Gama, Marco Antonio [6 ]
Ferraz Lopes, Fernando Cesar [6 ]
Gonzalez Garcia, Raul Marcel [1 ]
机构
[1] Univ Fed Juiz de Fora, Dept Biol, Juiz De Fora, MG, Brazil
[2] Univ Fed Juiz de Fora, Dept Nutr, Juiz De Fora, MG, Brazil
[3] Univ Fed Juiz de Fora, Dept Pharmaceut Sci, Juiz De Fora, MG, Brazil
[4] Univ Estado Rio De Janeiro, Roberto Alcantara Gomes Inst Biol, Dept Physiol Sci, Rio De Janeiro, Brazil
[5] Univ Fed Juiz de Fora, Dept Parasitol Microbiol & Immunol, Juiz De Fora, MG, Brazil
[6] Embrapa Dairy Cattle, Juiz De Fora, MG, Brazil
关键词
cis-9; trans-11; CLA; trans-10; cis-12; obesity; insulin resistance; dyslipidemia; CONJUGATED LINOLEIC-ACID; HIGH-DENSITY-LIPOPROTEINS; SPRAGUE-DAWLEY RATS; GLUCOSE-HOMEOSTASIS; LIPID-METABOLISM; ADIPOSE-TISSUE; FAT; OBESITY; SENSITIVITY; ISOMERS;
D O I
10.5650/jos.ess14222
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Synthetic supplements of conjugated linoleic acid (CLA) containing 50:50 mixture of cis-9, trans-11 and trans-10, cis-12 CLA isomers have been commercialized in some places for reducing body fat. However the safety of this CLA mixture is controversial and in some countries the CLA usage as food supplement is not authorized. Changes in insulinemic control and serum lipids profile are potential negative effects related to consumption of CLA mixture. The present study aimed to evaluate the effects of a diet containing mixture of cis-9, trans-11 and trans-10, cis-12 CLA on prevention of obesity risk as well as on potential side effects such as insulin resistance and dyslipidemia in Wistar rats. Thirty male Wistar rats were randomly assigned to the following dietary treatments (n=10/group), for 60 days: Normolipidic Control (NC), diet containing 4.0% soybean oil (SO); High Fat-Control (HF-C), diet containing 24.0% SO; High Fat-synthetic CIA (HF-CLA), diet containing 1.5% of an isomeric CLA mixture (Luta-CLA 60) and 22.5% SO. Luta-CLA 60 (BASF) contained nearly 60% of CLA (cis-9, trans-11 and trans-10, cis-12 CLA at 50:50 ratio). The HF-CLA diet contained 0.3% of each CLA isomer. HF-CLA diet had no effect on dietary intake and body composition. HF-CLA-fed rats had lower levels of PPAR gamma protein in retroperitoneal adipose tissue, hyperinsulinemia compared to HF-C-fed rats, hyperglycemia compared to NC-fed rats while no differences in glycemia were observed between NC and HF-C groups, increased HOMA index and higher levels of serum HDL cholesterol. Thus, feeding rats with a high fat diet containing equal parts of cis-9, trans-11 and trans-10, cis-12 CLA isomers had no effect on body composition and induced insulin resistance. Despite HF-CLA-fed rats had increased serum HDL cholesterol levels, caution should be taken before synthetic supplements containing cis-9, trans-11 and trans-10, cis-12 CLA are recommended as a nutritional strategy for weight management.
引用
下载
收藏
页码:539 / 551
页数:13
相关论文
共 50 条
  • [1] Oxidation kinetics for cis-9, trans-11 and trans-10, cis-12 isomers of CLA
    Adachi, S. (adachi@kais.kyoto-u.ac.jp), 1600, American Oil Chemists' Society (80):
  • [2] Oxidation kinetics for cis-9,trans-11 and trans-10,cis-12 isomers of CLA
    Minemoto, Y
    Adachi, S
    Shimada, Y
    Nagao, T
    Iwata, T
    Yamauchi-Sato, Y
    Yamamoto, T
    Kometani, T
    Matsuno, R
    JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 2003, 80 (07) : 675 - 678
  • [3] trans-10, cis-12, but not cis-9, trans-11 CLA isomer, inhibits brown adipocyte thermogenic capacity
    Rodríguez, E
    Ribot, J
    Palou, A
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2002, 282 (06) : R1789 - R1797
  • [4] Effects of trans-10,cis-12 and cis-9,trans-11 CLA on atherosclerosis in apoE/LDLR-/- mice
    Kostogrys, Renata B.
    Maslak, Edyta
    Franczyk-Zarow, Magdalena
    Gajda, Mariusz
    Chlopicki, Stefan
    EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, 2011, 113 (05) : 572 - 583
  • [5] Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men
    R Albers
    R P J van der Wielen
    E J Brink
    H F J Hendriks
    V N Dorovska-Taran
    I C M Mohede
    European Journal of Clinical Nutrition, 2003, 57 : 595 - 603
  • [6] Cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid isomers do not modify body composition in adult sedentary or exercised rats
    Mirand, PP
    Arnal-Bagnard, MA
    Mosoni, L
    Faulconnier, Y
    Chardigny, JM
    Chilliard, Y
    JOURNAL OF NUTRITION, 2004, 134 (09): : 2263 - 2269
  • [7] Effects of cis-9, trans-11 and trans-10, cis-12 CLA isomers on liver and adipose tissue fatty acid profile in hamsters
    Zabala, A.
    Portillo, M. P.
    Macarulla, M. T.
    Rodriguez, V. M.
    Fernandez-Quintela, A.
    LIPIDS, 2006, 41 (11) : 993 - 1001
  • [8] Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men
    Albers, R
    van der Wielen, RPJ
    Brink, EJ
    Hendriks, HFJ
    Dorovska-Taran, VN
    Mohede, ICM
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2003, 57 (04) : 595 - 603
  • [9] Incorporation of cis-9, trans-11 or trans-10, cis-12 conjugated linoleic acid into human erythrocytes in vivo
    Burdge, GC
    Derrick, PR
    Russell, JJ
    Tricon, S
    Kew, S
    Banerjee, T
    Grimble, RF
    Williams, CM
    Yaqoob, P
    Calder, PC
    NUTRITION RESEARCH, 2005, 25 (01) : 13 - 19
  • [10] cis-9, trans-11 and trans-10,cis-12 CLA affect lipid metabolism differently in primary white and brown adipocytes of Djungarian hamsters
    Metges, CC
    Lehmann, L
    Boeuf, S
    Petzke, KJ
    Müller, A
    Rickert, R
    Franke, W
    Steinhart, H
    Nürnberg, G
    Klaus, S
    LIPIDS, 2003, 38 (11) : 1133 - 1142